View Cart (0 items)

Pharmaceutical

Global spending on medicines to grow by up to 6% per year through 2017

No Comments
The key factors that will drive global drug markets are better access to medicines due to rising disposable income in developing countries and more favorable economic conditions in emerging markets.
Read More

FDA imposes new ban on Wockhardt drugs

No Comments
Indian generic drug maker Wockhardt has been hit by a U.S. import alert for the second time this year.
Read More

FDA seeks to ban dietary supplements unlawfully marketed as drugs

No Comments
The U.S. Food and Drug Administration has taken administrative action against a dietary supplement manufacturer following multiple breaches of the Federal Food, Drug and Cosmetic Act.
Read More

Generics dent market share of brand-name drugs

No Comments
The growth of the generic drug market worldwide may turn out to be a long-term trend, experts say, as a number of studies show a stable decline in prescriptions of brand-name drugs last year.
Read More

FDA publishes finalized guidance on medical apps

No Comments
The FDA will not be regulating the majority of medical apps because they pose very little health risk to patients, but will instead adopt a "risk-based approach."
Read More

FDA tightens grip on Indian drug makers

No Comments
The U.S. Food and Drug Administration (FDA) has warned two Indian pharmaceutical companies over suspected breaches of good manufacturing practices.
Read More

FDA reiterates warning over NuVision's sterile products

No Comments
The U.S. Food and Drug Administration (FDA) has issued another alert over sterile products manufactured by Dallas-based NuVision Pharmacy.
Read More

GlaxoSmithKline sets up $50 million fund to develop bioelectronic medicines

No Comments
UK-based GlaxoSmithKline, one of the biggest pharmaceutical companies on the planet, wants to be a leader in the bioelectronic medicines space.
Read More

Chinese pharma probe spreads to two Danish drug makers

No Comments
Western pharmaceutical companies are coming under increased scrutiny in China following the bribery accusations leveled last month against GlaxoSmithKline (GSK).
Read More

Generic drug patent settlements cut costs for health systems, study finds

No Comments
The U.S. health system saved a total of $25.5 billion between 2005 and 2012 thanks to generic drugs being launched on the market before patent expirations as a result of patent settlements.
Read More